BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Won Sik Lee, Dr. PhD.
Inje University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Inje University Busan Paik Hospital
Busan, Busan, South Korea
Won Sik Lee, M.D. PhD.Recruiting - Asan Medical Center, University of Ulsan
Seoul, South Korea
Je Hwan Lee, M.D. Ph.D.Recruiting - Seoul National University Hospital
Seoul, South Korea
Sung Soo Yoon, M.D. Ph.D.Recruiting - Yeonsei University Hospital
Seoul, South Korea
Jin Seok Kim, M.D. Ph.D.Recruiting - Ulsan University Hospital
Ulsan, South Korea
Hawk Kim, M.D. Ph. D.Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2010
- Primary completion
- 31 Aug 2014
- Completion
- 28 Feb 2015
- Last update posted
- 2 Dec 2010
- Registered enrollment
- 42
- Registry id
- NCT01063439
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.